Authorities Clarify Patent Law Amendment

BMI has upgraded China's patented drug market forecast following clarification of the country's intellectual property law. Clear legal definitions of fundamental terms such as 'patented pharmaceutical' will provide assurances to foreign multinationals looking to launch their products in the most promising emerging pharmaceutical market in the world. Sales of patented drugs in China are expected to increase from US$4.5bn in 2009 to US$28.6bn in 2019, representing a compound annual growth rate (CAGR) of 20.3%.

To read the full article, please choose one of the following options: